Pacific Edge's APAC operations advancing towards profit with cancer test growth
Pacific Edge APAC business is advancing towards profitability on a direct-cost basis with a growing interest in its testing services.
Market Cap $15.90M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
No News & Media currently available.
